Return On Equity in % of Replimune Group, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Replimune Group, Inc. quarterly/annual Return On Equity history and change rate from Q4 2018 to Q3 2025.
  • Replimune Group, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -82.8 %, a 55.9% decline year-over-year.
  • Replimune Group, Inc. annual Return On Equity for 2024 was -55.7 %, a 25.6% decline from 2023.
  • Replimune Group, Inc. annual Return On Equity for 2023 was -44.4 %, a 13.6% decline from 2022.
  • Replimune Group, Inc. annual Return On Equity for 2022 was -39.1 %, a 28.5% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Replimune Group, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -82.8 -29.7 -55.9% 01 Jul 2025 30 Sep 2025
Q2 2025 -69.3 -17.2 -33% 01 Apr 2025 30 Jun 2025
Q1 2025 -58 -9.36 -19.3% 01 Jan 2025 31 Mar 2025
Q4 2024 -54.8 -11.9 -27.7% 01 Oct 2024 31 Dec 2024
Q3 2024 -53.1 -15.8 -42.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -52.2 -16.7 -47.1% 01 Apr 2024 30 Jun 2024
Q1 2024 -48.6 -12.8 -35.7% 01 Jan 2024 31 Mar 2024
Q4 2023 -42.9 -8.12 -23.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -37.3 -1.57 -4.4% 01 Jul 2023 30 Sep 2023
Q2 2023 -35.5 -4.46 -14.4% 01 Apr 2023 30 Jun 2023
Q1 2023 -35.8 -9.39 -35.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -34.8 -11.8 -51.1% 01 Oct 2022 31 Dec 2022
Q3 2022 -35.7 -15.2 -74.3% 01 Jul 2022 30 Sep 2022
Q2 2022 -31 -10.3 -49.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -26.5 -5.63 -27% 01 Jan 2022 31 Mar 2022
Q4 2021 -23 +1.23 +5.07% 01 Oct 2021 31 Dec 2021
Q3 2021 -20.5 +9.74 +32.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -20.7 +10.4 +33.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -20.8 +12.5 +37.5% 01 Jan 2021 31 Mar 2021
Q4 2020 -24.3 +5.41 +18.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -30.2 -3.93 -14.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -31.1 -9.5 -44% 01 Apr 2020 30 Jun 2020
Q1 2020 -33.3 -1.87 -5.95% 01 Jan 2020 31 Mar 2020
Q4 2019 -29.7 +25.6 +46.3% 01 Oct 2019 31 Dec 2019
Q3 2019 -26.3 01 Jul 2019 30 Sep 2019
Q2 2019 -21.6 01 Apr 2019 30 Jun 2019
Q1 2019 -31.4 01 Jan 2019 31 Mar 2019
Q4 2018 -55.3 01 Oct 2018 31 Dec 2018

Replimune Group, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -55.7 -11.3 -25.6% 01 Apr 2024 31 Mar 2025
2023 -44.4 -5.33 -13.6% 01 Apr 2023 31 Mar 2024
2022 -39.1 -8.67 -28.5% 01 Apr 2022 31 Mar 2023
2021 -30.4 +20.8 +40.6% 01 Apr 2021 31 Mar 2022
2020 -51.2 +2.46 +4.59% 01 Apr 2020 31 Mar 2021
2019 -53.6 01 Apr 2019 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.